Extension Data Reported for Chronic Hand Eczema Treatment : vimarsana.com

Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.

Related Keywords

Japan , Illinois , United States , San Diego , California , Northwestern University , Chicago , Canada , American , Raj Chovatiya , Melissa Gooderham , European Academy Of Dermatology , American Academy Of Dermatology , Queen University , Journal Of The American Medical Association , Skin Centre For Dermatology , American Academy , Skin Centre , European Academy , Studies Were , Global Assessment , Primary Endpoints Were , Hand Eczema Severity Index , Dermatology Life Quality Index , American Medical Association , Medscape Medical , Dermatitis , Eczema , Hands , Atopic Dermatitis , Topic Eczema , Pain Management , Otolaryngology , Nt Specialty , Ead And Neck Surgery Ent Speciality , Back Pain , Pain , Biologic Therapy , Iologics , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Covid 19 , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e ,